PATENT CLAIM ANALYSIS

Application Number: 15906163
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-12
Patent Classification: ["514", "230200"]

Abstract:
The present invention relates to tricyclic heterocycles of Formula (I): which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.

Claim (Index 30):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein Cy 3  is oxidopyridinyl optionally substituted with 1, 2, 3, or 4 groups independently selected from R 13 .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.24242
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15398907', '14852958', '14923105', '14212721', '15356002']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8632484270040796
- 35 USC 102 Novelty (BERT): 0.6717000399071651
- Combined Prediction Score: 0.8440935882943881
- Mean Citation Score: 617.0727119999998
- Max Citation Score: 685.05786
- Similarity Product: 656.1451319019093

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test